This concept is in accordance with the experimental demonstration of anti-tumor effects of D2-HG, which decreases the stability of MYC/CEBPA transcripts via N6-methyladenosine RNA modification and thereby inhibits tumor cell survival and proliferation [14]. The gene discussed is MYC; the disease is neoplasm.